Updates on Drug Designing Approach Through Computational Strategies: a Review

References

• CeylanZ , MeralR , CetinkayaT. Relevance of SARS-CoV-2 in food safety and food hygiene: potential preventive measures, suggestions and nanotechnological approaches. VirusDisease31(2), 154–160 (2020).
   PubMedGoogle Scholar
• MohantySK , SatapathyA , NaiduMMet al.Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)- A natomic pathology perspective on current knowledge [internet]. Diagn. Pathol.15(1), 103 (2020).
   PubMed Web of Science ®Google Scholar
• LaiCC , ShihTP , KoWC , TangHJ , HsuehPR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents55(3), 105924 (2020).
   PubMed Web of Science ®Google Scholar
• WuD , WuT , LiuQ , YangZ. The SARS-CoV-2 outbreak: what we know. Int. J. Infect. Dis.94, 44–48 (2020).
   PubMed Web of Science ®Google Scholar
• MacKenzieJS , SmithDW. COVID-19: a novel zoonotic disease caused by a coronavirus from China: What we know and what we don't. Microbiol. Aust.41(1), 45–50 (2020).
   Web of Science ®Google Scholar
• WuZ , McGooganJM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J. Am. Med. Assoc.323(13), 1239–1242 (2020).
   PubMed Web of Science ®Google Scholar
• ChaddaRK , DebKS. Indian family systems, collectivistic society and psychotherapy. Indian J. Psychiatry.55(Suppl. SPEC.), S299–S309 (2013).
   PubMedGoogle Scholar
• SunW , SandersonPE , ZhengW. Drug combination therapy increases successful drug repositioning. Drug Discov. Today21(7), 1189–1195 (2016).
   PubMed Web of Science ®Google Scholar
• KhannaR , CicinelliM , GilbertS , HonavarS , MurthyGV. COVID-19 pandemic: lessons learned and future directions. Indian J. Ophthalmol.68(5), 703 (2020).
   PubMed Web of Science ®Google Scholar
• VanDer Gronde T , Uyl-DeGroot CA , PietersT. Addressing the challenge of high-priced prescription drugs in the era of precision medicine: a systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks. PLOS ONE12(8), e0182613 (2017).
   PubMed Web of Science ®Google Scholar
• HwangTJ , CarpenterD , LauffenburgerJC , WangB , FranklinJM , KesselheimAS. Failure of investigational drugs in late-stage clinical development and publication of trial results. JAMA Intern. Med.176(12), 1826–1833 (2016).
   PubMed Web of Science ®Google Scholar
• TiloccaB , BrittiD , UrbaniA , RoncadaP. Computational Immune Proteomics Approach to Target COVID-19. J. Proteome Res.19(11), 4233–4241 (2020).
   PubMed Web of Science ®Google Scholar
• SchaduangratN , LampaS , SimeonS , GleesonMP , SpjuthO , NantasenamatC. Towards reproducible computational drug discovery. J. Cheminform.12(1), 1–30 (2020).
   PubMed Web of Science ®Google Scholar
• WilsonRC , CollinsAGE. Ten simple rules for the computational modeling of behavioral data. Elife8, e49547 (2019).
   PubMed Web of Science ®Google Scholar
• LinJ , SahakianD , de MoraisS , XuJ , PolzerR , WinterS. The Role of Absorption, Distribution, Metabolism, Excretion and Toxicity in Drug Discovery. Curr. Top. Med. Chem.3(10), 1125–1154 (2005).
   Web of Science ®Google Scholar
• LoYC , RensiSE , TorngW , AltmanRB. Machine learning in chemoinformatics and drug discovery. Drug Discov. Today23(8), 1538–1546 (2018).
   PubMed Web of Science ®Google Scholar
• KirchmairJ , WilliamsonMJ , TyzackJDet al.Computational prediction of metabolism: Sites, products, SAR, P450 enzyme dynamics, and mechanisms. J. Chem. Inf. Model.52(3), 617–648 (2012).
   PubMed Web of Science ®Google Scholar
• SliwoskiG , KothiwaleS , MeilerJ , LoweEW. Computational methods in drug discovery. Pharmacol. Rev.66(1), 334–395 (2014).
   PubMed Web of Science ®Google Scholar
• TiwariMK , SinghR , SinghRK , KimIW , LeeJK. Computational approaches for rational design of proteins with novel functionalities. Comput. Struct. Biotechnol. J.2(3), e201204002 (2012).
   Google Scholar
• Sequeiros-BorjaCE , SurpetaB , BrezovskyJ. Recent advances in user-friendly computational tools to engineer protein function. Brief. Bioinform.2020(00), 1–15 (2020).
   Google Scholar
• ZhouSF , ZhongWZ. Drug design and discovery: principles and applications. Molecules.22(2), 279 (2017).
   PubMed Web of Science ®Google Scholar
• AndersonAC. The process of structure-based drug design. Chem. Biol.10(9), 787–797 (2003).
   PubMed Web of Science ®Google Scholar
• ChadhaN , SinghD , MiltonMDet al.Computational prediction of interaction and pharmacokinetics profile study for polyamino-polycarboxylic ligands on binding with human serum albumin. New J. Chem.44(7), 2907–2918 (2020).
   Web of Science ®Google Scholar
• SalahudeenMS , NishtalaPS. An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice. Saudi Pharm. J.25(2), 165–175 (2017).
   PubMed Web of Science ®Google Scholar
• ZhaoJ , CaoY , ZhangL. Exploring the computational methods for protein-ligand binding site prediction. Comput. Struct. Biotechnol. J.18, 417–426 (2020).
   PubMed Web of Science ®Google Scholar
• KennethMorrow J , ZhangS. Computational Prediction of Protein Hot Spot Residues. Curr. Pharm. Des.18(9), 1255–1265 (2012).
   PubMed Web of Science ®Google Scholar
• KhazanovNA , CarlsonHA. Exploring the Composition of Protein-Ligand Binding Sites on a Large Scale. PLOS Comput. Biol.9(11), 1003321 (2013).
   PubMed Web of Science ®Google Scholar
• GuedesIA , de MagalhãesCS , DardenneLE. Receptor-ligand molecular docking. Biophys. Rev.6(1), 75–87 (2014).
   PubMedGoogle Scholar
• MengX-Y , ZhangH-X , MezeiM , CuiM. Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery. Curr. Comput. Aided-Drug Des.7(2), 146–157 (2012).
   Web of Science ®Google Scholar
• RamírezD , CaballeroJ. Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?Molecules.23(5), 1038 (2018).
   PubMed Web of Science ®Google Scholar
• LiontaE , SpyrouG , VassilatisD , CourniaZ. Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances. Curr. Top. Med. Chem.14(16), 1923–1938 (2014).
   PubMed Web of Science ®Google Scholar
• PagadalaNS , SyedK , TuszynskiJ. Software for molecular docking: a review. Biophys. Rev.9(2), 91–102 (2017).
   PubMedGoogle Scholar
• PantsarT , PosoA. Binding affinity via docking: fact and fiction. Molecules.23(8), 1899 (2018).
   PubMed Web of Science ®Google Scholar
• GuedesIA , PereiraFSS , DardenneLE. Empirical scoring functions for structure-based virtual screening: applications, critical aspects, and challenges. Front. Pharmacol.9(SEP), 1089 (2018).
   PubMedGoogle Scholar
• LamPC-H , AbagyanR , TotrovM. Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach. J. Comput. Aided. Mol. Des.32(1), 187–198 (2018).
   PubMed Web of Science ®Google Scholar
• ShoichetBK. Virtual screening of chemical libraries. Nature432(7019), 862–865 (2004).
   PubMed Web of Science ®Google Scholar
• PathanH , WilliamsJ. Basic opioid pharmacology: an update. Br. J. Pain.6(1), 11–16 (2012).
   PubMedGoogle Scholar
• SzymańskiP , MarkowiczM , Mikiciuk-OlasikE. Adaptation of high-throughput screening in drug discovery-toxicological screening tests. Int. J. Mol. Sci.13(1), 427–452 (2012).
   PubMed Web of Science ®Google Scholar
• NascimentoIJ dos S , de AquinoTM , da Silva-JúniorEF. The New Era of Drug Discovery: The Power of Computer-aided Drug Design (CADD). Lett. Drug Des. Discov.19(11), 951–955 (2022).
   Web of Science ®Google Scholar
• BickertonGR , PaoliniGV , BesnardJ , MuresanS , HopkinsAL. Quantifying the chemical beauty of drugs. Nat. Chem.4(2), 90–98 (2012).
   PubMed Web of Science ®Google Scholar
• LimSV , RahmanMBA , TejoBA. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus. BMC Bioinformatics.12(Suppl. 13), S24 (2011).
   PubMedGoogle Scholar
• YasuoN , SekijimaM. Improved Method of Structure-Based Virtual Screening via Interaction-Energy-Based Learning. J. Chem. Inf. Model.59(3), 1050–1061 (2019).
   PubMed Web of Science ®Google Scholar
• SinghN , ChaputL , VilloutreixBO. Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace. Brief. Bioinform.22(2), 1790–1818 (2021).
   Web of Science ®Google Scholar
• SchneiderM , PonsJ-L , BourguetW , LabesseG. Towards accurate high-throughput ligand affinity prediction by exploiting structural ensembles, docking metrics and ligand similarity. Bioinformatics.36(1), 160–168 (2020).
   PubMed Web of Science ®Google Scholar
• Crampon K, Giorkallos A, Deldossi M, Baud S, Steffenel LA.Machine-learning methods for ligand–protein molecular docking.Drug Discovery Today27(1), 151–164 (2022).
   PubMed Web of Science ®Google Scholar
• AparoyP , KumarReddy K , ReddannaP. Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors. Curr. Med. Chem.19(22), 3763–3778 (2012).
   PubMed Web of Science ®Google Scholar
• GaoH , WilliamsC , LabuteP , BajorathJ. Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands. J. Chem. Inf. Comput. Sci.39(1), 164–168 (1999).
   PubMedGoogle Scholar
• BelleraCL , TaleviA. Quantitative structure–activity relationship models for compounds with anticonvulsant activity. Expert Opin. Drug Discov.14(7), 653–665 (2019).
   PubMed Web of Science ®Google Scholar
• VermaJ , KhedkarV , CoutinhoE. 3D-QSAR in Drug Design - A Review. Curr. Top. Med. Chem.10(1), 95–115 (2010).
   PubMed Web of Science ®Google Scholar
• JhotiH , ReesS , SolariR. High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?. Expert Opin. Drug Discov.8(12), 1449–1453 (2013).
   PubMed Web of Science ®Google Scholar
• LiontaE , SpyrouG , VassilatisD , CourniaZ. Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances. Curr. Top. Med. Chem.14(16), 1923–1938 (2014).
   PubMed Web of Science ®Google Scholar
• BatoolM , AhmadB , ChoiS. A structure-based drug discovery paradigm. Int. J. Mol. Sci.20(11), 2783 (2019).
   PubMed Web of Science ®Google Scholar
• FrançaTCC. Homology modeling: an important tool for the drug discovery. J. Biomol. Struct. Dyn.33(8), 1780–1793 (2015).
   PubMed Web of Science ®Google Scholar
• PapadopoulosJS , AgarwalaR. COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics.23(9), 1073–1079 (2007).
   PubMed Web of Science ®Google Scholar
• LassmannT , SonnhammerELL. Kalign - An accurate and fast multiple sequence alignment algorithm. BMC Bioinformatics.6(1), 298 (2005).
   PubMedGoogle Scholar
• SieversF , HigginsDG. Clustal omega, accurate alignment of very large numbers of sequences. Methods Mol. Biol.1079, 105–116 (2014).
   PubMedGoogle Scholar
• McGinnisS , MaddenTL. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res.32(WEB SERVER ISS.), W20–25 (2004).
   PubMedGoogle Scholar
• dosSantos Nascimento IJ , daSilva Santos-Júnior PF , de Araújo-JúniorJX , da Silva-JúniorEF. Strategies in Medicinal Chemistry to Discover New Hit Compounds against Ebola Virus: Challenges and Perspectives in Drug Discovery. Mini-Reviews Med. Chem.22(22), 2896–2924 (2022).
   PubMed Web of Science ®Google Scholar
• ShenM , TianS , LiYet al.Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines. J. Cheminform.4(1), 31 (2012).
   PubMedGoogle Scholar
• KalyaanamoorthyS , ChenYPP. Structure-based drug design to augment hit discovery. Drug Discov. Today16(17–18), 831–839 (2011).
   PubMed Web of Science ®Google Scholar
• HetényiC , VanDer Spoel D. Blind docking of drug-sized compounds to proteins with up to a thousand residues. FEBS Lett.580(5), 1447–1450 (2006).
   PubMed Web of Science ®Google Scholar
• KumaranD , RawatR , AhmedSA , SwaminathanS. Substrate binding mode and its implication on drug design for botulinum neurotoxin A. PLoS Pathog.4(9), 1000165 (2008).
   PubMed Web of Science ®Google Scholar
• RayS , SrivastavaS. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research. Omi. A J. Integr. Biol.24(8), 457–459 (2020).
   PubMed Web of Science ®Google Scholar
• OvermyerKA , ShishkovaE , MillerIJet al.Large-Scale Multi-omic Analysis of COVID-19 Severity. Cell Syst.14(1), 23–40.e7 (2021).
   Google Scholar
• YuW , MackerellAD.Computer-aided drug design methods. In: Antibiotics. Methods in Molecular Biology.SassP ( Eds). Humana Press Inc, New York, NY, USA, 1520, 85–106 (2017).
   Google Scholar
• IvorraB , FerrándezMR , Vela-PérezM , RamosAM. Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections. The case of China. Commun. Nonlinear Sci. Numer. Simul.88, 105303 (2020).
   PubMed Web of Science ®Google Scholar
• RobsonB. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance. Comput. Biol. Med.121, 103749 (2020).
   PubMed Web of Science ®Google Scholar
• CarterLJ , GarnerLV , SmootJWet al.Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Cent. Sci.6(5), 591–605 (2020).
   PubMed Web of Science ®Google Scholar
• ShujaJ , AlanaziE , AlasmaryW , AlashaikhA. COVID-19 open source data sets: a comprehensive survey. Appl. Intell.51(3), 1296–1325 (2021).
   PubMed Web of Science ®Google Scholar
• PierleoniA , MartelliPL , FariselliP , CasadioR. eSLDB: eukaryotic subcellular localization database. Nucleic Acids Res.35(Suppl. 1), D208–212 (2007).
   PubMedGoogle Scholar
• PeabodyMA , LairdMR , VlasschaertC , LoR , BrinkmanFSL. PSORTdb: expanding the bacteria and archaea protein subcellular localization database to better reflect diversity in cell envelope structures. Nucleic Acids Res.44(D1), D663–D668 (2016).
   PubMed Web of Science ®Google Scholar
• SprengerJ , LynnFink J , KarunaratneS , HansonK , HamiltonNA , TeasdaleRD. LOCATE: a mammalian protein subcellular localization database. Nucleic Acids Res.36(Suppl. 1), D230–233 (2008).
   PubMedGoogle Scholar
• HendlichM , BergnerA , GüntherJ , KlebeG. Relibase: design and development of a database for comprehensive analysis of protein-ligand interactions. J. Mol. Biol.326(2), 607–620 (2003).
   PubMed Web of Science ®Google Scholar
• ChenX , LinY , LiuM , GilsonMK. The binding database: data management and interface design. Bioinformatics.18(1), 130–139 (2002).
   PubMed Web of Science ®Google Scholar
• SalwinskiL , MillerCS , SmithAJ , PettitFK , BowieJU , EisenbergD. The Database of Interacting Proteins: 2004 update. Nucleic Acids Res.32(DATABASE ISS.), D449 (2004).
   PubMedGoogle Scholar
• OughtredR , StarkC , BreitkreutzBJet al.The BioGRID interaction database: 2019 update. Nucleic Acids Res.47(D1), D529–D541 (2019).
   PubMed Web of Science ®Google Scholar
• JensenLJ , KuhnM , StarkMet al.STRING 8 - A global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res.37(Suppl. 1), D412 (2009).
   PubMedGoogle Scholar
• GhaniSS. A comprehensive review of database resources in chemistry. Eclet. Quim.45(3), 57–68 (2020).
   Google Scholar
• MaiaEHB , AssisLC , de OliveiraTA , da SilvaAM , TarantoAG. Structure-Based Virtual Screening: From Classical to Artificial Intelligence. Front. Chem.8, 343 (2020).
   PubMed Web of Science ®Google Scholar
• YasuoN , SekijimaM. Improved Method of Structure-Based Virtual Screening via Interaction-Energy-Based Learning. J. Chem. Inf. Model.59(3), 1050–1061 (2019).
   PubMed Web of Science ®Google Scholar
• ChenP , KeY , LuYet al.Dligand2: an improved knowledge-based energy function for protein–ligand interactions using the distance-scaled, finite, ideal-gas reference state. J. Cheminform.11(1), 52 (2019).
   PubMed Web of Science ®Google Scholar
• dosSantos Nascimento IJ , daSilva Rodrigues ÉE , da SilvaMF , de Araújo-JúniorJX , de MouraRO. Advances in Computational Methods to Discover New NS2B–NS3 Inhibitors Useful Against Dengue and Zika Viruses. Curr. Top. Med. Chem.22(29), 2435–2462 (2022).
   PubMed Web of Science ®Google Scholar
• SugawaraT , BaumgartSJ , NevedomskayaEet al.Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models. Int. J. Cancer145(5), 1382 (2019).
   PubMed Web of Science ®Google Scholar
• CurtinNJ. The Development of Rucaparib/Rubraca®: A Story of the Synergy Between Science and Serendipity. Cancers (Basel).12(3), 564 (2020).
   PubMed Web of Science ®Google Scholar
• KimA , CohenMS. The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma. Expert Opin. Drug Discov.11(9), 907 (2016).
   PubMed Web of Science ®Google Scholar
• PollyeaDA , AmayaM , StratiP , KonoplevaMY. Venetoclax for AML: changing the treatment paradigm. Blood Adv.3(24), 4326 (2019).
   PubMed Web of Science ®Google Scholar
• PaulD , SanapG , ShenoyS , KalyaneD , KaliaK , TekadeRK. Artificial intelligence in drug discovery and development. Drug Discov. Today26(1), 80–93 (2021).
   PubMed Web of Science ®Google Scholar
• CarpenterKA , HuangX. Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review. Curr. Pharm. Des.24(28), 3347–3358 (2018).
   PubMed Web of Science ®Google Scholar
• PuL , NaderiM , LiuT , WuHC , MukhopadhyayS , BrylinskiM. EToxPred: a machine learning-based approach to estimate the toxicity of drug candidates 11 Medical and Health Sciences 1115 Pharmacology and Pharmaceutical Sciences 03 Chemical Sciences 0305 Organic Chemistry 03 Chemical Sciences 0304 Medicinal and Biomolecular Chemistry. BMC Pharmacol. Toxicol.20(1), 2 (2019).
   PubMedGoogle Scholar
• LipinskiCF , MaltarolloVG , OliveiraPR , da SilvaABF , HonorioKM. Advances and Perspectives in Applying Deep Learning for Drug Design and Discovery. Front. Robot. AI.6, 108 (2019).
   PubMed Web of Science ®Google Scholar
• LinX , LiX , LinX. A review on applications of computational methods in drug screening and design. Molecules25(6), 1375 (2020).
   PubMed Web of Science ®Google Scholar
• LeelanandaSP , LindertS. Computational methods in drug discovery. Beilstein J. Org. Chem.12(1), 2694–2718 (2016).
   PubMedGoogle Scholar
• MuratovEN , BajorathJ , SheridanRPet al.QSAR without borders. Chem. Soc. Rev.49(11), 3525–3564 (2020).
   PubMed Web of Science ®Google Scholar
• MouchlisVD , AfantitisA , SerraAet al.Advances in De Novo Drug Design: From Conventional to Machine Learning Methods. Int. J. Mol. Sci.22(4), 1–22 (2021).
   Web of Science ®Google Scholar
• FerreiraLG , DosSantos RN , OlivaG , AndricopuloAD. Molecular Docking and Structure-Based Drug Design Strategies. Molecules.20(7), 13384–13421 (2015).
   PubMed Web of Science ®Google Scholar
• PalazzesiF , PozzanA. Deep Learning Applied to Ligand-Based De Novo Drug Design. Methods Mol. Biol.2390, 273–299 (2022).
   PubMedGoogle Scholar
• ZhangY , LiS , XingM , YuanQ , HeH , SunS. Universal Approach to De Novo Drug Design for Target Proteins Using Deep Reinforcement Learning. ACS Omega [Internet].8(6), 5464–5474 (2023).
   PubMedGoogle Scholar
• BaiQ , LiuS , TianYet al.Application advances of deep learning methods for de novo drug design and molecular dynamics simulation. Wiley Interdiscip. Rev. Comput. Mol. Sci.12(3), e1581 (2022).
   Web of Science ®Google Scholar
• HillischA , PinedaLF , HilgenfeldR. Utility of homology models in the drug discovery process. Drug Discov. Today9(15), 659–669 (2004).
   PubMed Web of Science ®Google Scholar
• FiserA. Template-based protein structure modeling. Methods Mol. Biol.673, 73–94 (2010).
   PubMedGoogle Scholar
• McKeageK , PerryCM , KeamSJ. Darunavir: a review of its use in the management of HIV infection in adults. Drugs69(4), 477–503 (2009).
   PubMed Web of Science ®Google Scholar
• NurwidyaF , TakahashiF , TakahashiK. Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation. J. Nat. Sci. Biol. Med.7(2), 119 (2016).
   PubMedGoogle Scholar
• BellesoeurA , CartonE , AlexandreJ , GoldwasserF , HuillardO. Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy. Drug Des. Devel. Ther.11, 2801 (2017).
   PubMed Web of Science ®Google Scholar
• VélezDe Mendizábal N , StrotherRM , FaragSSet al.Modeling Sitagliptin Effect on Dipeptidyl Peptidase 4 (DPP4) Activity inAdults with Hematological Malignancies After Umbilical Cord Blood (UCB) Hematopoietic CellTransplant (HCT). Clin. Pharmacokinet.53(3), 247 (2014).
   PubMedGoogle Scholar
• dosSantos Nascimento IJ , de AquinoTM , daSilva Júnior EF. Computer-Aided Drug Design of Anti-inflammatory Agents Targeting Microsomal Prostaglandin E2 Synthase-1 (mPGES-1). Curr. Med. Chem.29(33), 5397–5419 (2022).
   PubMed Web of Science ®Google Scholar
• MazumderM , PonnanP , DasUet al.Investigations on Binding Pattern of Kinase Inhibitors with PPAR γ: Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation Studies. PPAR Res.2017, (2017).
   PubMed Web of Science ®Google Scholar
• RamírezD , CaballeroJ. Is it reliable to use common molecular docking methods for comparing the binding affinities of enantiomer pairs for their protein target?Int. J. Mol. Sci.17(4), 525 (2016).
   PubMed Web of Science ®Google Scholar
• PantsarT , PosoA. Binding affinity via docking: fact and fiction. Molecules.23(8), 1899 (2018).
   PubMed Web of Science ®Google Scholar
• GuedesIA , BarretoAMS , MarinhoDet al.New machine learning and physics-based scoring functions for drug discovery. Sci Rep11, 3198 (2021).
   PubMedGoogle Scholar
• SalmasoV , MoroS. Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview. Front. Pharmacol.9(AUG), 923 (2018).
   PubMedGoogle Scholar
• MengX-Y , ZhangH-X , MezeiM , CuiM. Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery. Curr. Comput. Aided-Drug Des.7(2), 146–157 (2012).
   Web of Science ®Google Scholar
• TA , VAB. Molecular Docking: From Lock and Key to Combination Lock. J. Mol. Med. Clin. Appl.2(1), https://doi.org/10.16966/2575-0305.106 (2018).
   Google Scholar
• LexaKW , CarlsonHA. Protein flexibility in docking and surface mapping Q. Rev. Biophys.45(3), 301–343 (2012).
   PubMed Web of Science ®Google Scholar
• AndrusierN , MashiachE , NussinovR , WolfsonHJ. Principles of flexible protein-protein docking Proteins Struct. Funct. Genet.73(2), 271–289 (2008).
   PubMed Web of Science ®Google Scholar
• MorrisGM , GoodsellDS , HallidayRSet al.Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem.19(14), 1639–1662 (1998).
   Web of Science ®Google Scholar
• TorresPHM , SoderoACR , JofilyP , Silva-JrFP. Key topics in molecular docking for drug design. Int. J. Mol. Sci.20(18), 4574 (2019).
   PubMed Web of Science ®Google Scholar
• AgrawalP , SinghH , SrivastavaHK , SinghS , KishoreG , RaghavaGPS. Benchmarking of different molecular docking methods for protein-peptide docking. BMC Bioinformatics19(Suppl. 13), 426 (2019).
   PubMedGoogle Scholar
• MorrisGM , RuthH , LindstromWet al.Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. [Internet].30(16), 2785–2791 (2009).
   PubMed Web of Science ®Google Scholar
• TrottO , OlsonAJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem.31(2), 455–461 (2009).
   Web of Science ®Google Scholar
• SandeepG , NagasreeKP , HanishaM , KumarMMK. AUDocker LE: a GUI for virtual screening with AUTODOCK Vina. BMC Res. Notes.4(1), 445 (2011).
   PubMedGoogle Scholar
• RavindranathPA , ForliS , GoodsellDS , OlsonAJ , SannerMF. AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility. PLOS Comput. Biol.11(12), e1004586 (2015).
   PubMed Web of Science ®Google Scholar
• HsuKC , ChenYF , LinSR , YangJM. Igemdock: a graphical environment of enhancing gemdock using pharmacological interactions and post-screening analysis. BMC Bioinformatics.12(Suppl. 1), S33 (2011).
   PubMed Web of Science ®Google Scholar
• JamkhandePG , GhanteMH , AjgundeBR. Software based approaches for drug designing and development: a systematic review on commonly used software and its applications. Bull. Fac. Pharmacy, Cairo Univ.55(2), 203–210 (2017).
   Google Scholar
• TalluriS. Molecular Docking and Virtual Screening based prediction of drugs for COVID-19. Comb. Chem. High Throughput Screen.23, 716–728 (2020).
   Google Scholar
• OferkinIV , KatkovaEV , SulimovAVet al.Evaluation of Docking Target Functions by the Comprehensive Investigation of Protein-Ligand Energy Minima. Adv. Bioinformatics2015, 1–12 (2015).
   Google Scholar
• MalmstromRD , WatowichSJ. Using free energy of binding calculations to improve the accuracy of virtual screening predictions. J. Chem. Inf. Model.51(7), 1648–1655 (2011).
   PubMed Web of Science ®Google Scholar
• AdcockSA , McCammonJA. Molecular dynamics: survey of methods for simulating the activity of proteins. Chem. Rev.106(5), 1589–1615 (2006).
   PubMed Web of Science ®Google Scholar
• HollingsworthSA , DrorRO. Molecular Dynamics Simulation for All. Neuron99(6), 1129–1143 (2018).
   PubMed Web of Science ®Google Scholar
• GhahremanianS , RashidiMM , RaeisiK , ToghraieD. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review. J Mol Liq.15(354), 118901 (2022).
   Google Scholar
• LeeD , JoH , JangYet al.Alloferon and Zanamivir Show Effective Antiviral Activity against Influenza A Virus (H1N1) Infection In Vitro and In Vivo. Int. J. Mol. Sci.24(1), 678 (2023).
   Web of Science ®Google Scholar
• IqbalN , IqbalN. Imatinib: A Breakthrough of Targeted Therapy in Cancer. Chemother. Res. Pract.2014, 1–9 (2014).
   Google Scholar
• LipworthBJ , AzizI. Bronchodilator Response to Albuterol After Regular Formoterol and Effects of Acute Corticosteroid Administration. Chest117(1), 156–162 (2000).
   PubMed Web of Science ®Google Scholar
• HospitalA , GoñiJR , OrozcoM , GelpíJL. Molecular dynamics simulations: advances and applications. Adv. Appl. Bioinforma. Chem.8(1), 37–47 (2015).
   PubMedGoogle Scholar
• ZhangL , LiQ , TianS , HongG. Molecular Dynamics Simulation of the Cu/Au Nanoparticle Alloying Process. J. Nanomater.2019, 1–7 (2019).
   Web of Science ®Google Scholar
• BraySimon. Running molecular dynamics simulations using GROMACS. (2022).
   Google Scholar
• FaizaMuniba. Tutorial: molecular dynamics (MD) simulation using Gromacs. Bioinformatics Review.5(12), (2019). https://bioinformaticsreview.com/20191210/tutorial-molecular-dynamics-md-simulation-using-gromacs/?v=c86ee0d9d7ed
   Google Scholar
• DixitVA , BharatamPV. SAR and Computer-Aided Drug Design Approaches in the Discovery of Peroxisome Proliferator-Activated Receptor γ Activators: A Perspective. J. Comput. Med.2013, 1–38 (2013).
   Google Scholar
• RichterL. Topliss Batchwise Schemes Reviewed in the Era of Open Data Reveal Significant Differences between Enzymes and Membrane Receptors. J. Chem. Inf. Model.57(10), 2575–2583 (2017).
   PubMed Web of Science ®Google Scholar
• SchäferT , KriegeN , HumbeckL , KleinK , KochO , MutzelP. Scaffold Hunter: a comprehensive visual analytics framework for drug discovery. J. Cheminform.9(1), 28 (2017).
   PubMedGoogle Scholar
• VázquezJ , LópezM , GibertE , HerreroE , JavierLuque F. Merging ligand-based and structure-based methods in drug discovery: an overview of combined virtual screening approaches. Molecules25(20), 4723 (2020).
   PubMed Web of Science ®Google Scholar
• Banegas-LunaAJ , Cerón-CarrascoJP , Pérez-SánchezH. A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data. Future Med. Chem.10(22), 2641–2658 (2018).
   PubMed Web of Science ®Google Scholar
• SterlingT , IrwinJJ. ZINC 15 - Ligand Discovery for Everyone. J. Chem. Inf. Model.55(11), 2324–2337 (2015).
   PubMed Web of Science ®Google Scholar
• KadamR , RoyN. Recent trends in drug-likeness prediction: a comprehensive review of in silico methods. Indian J. Pharm. Sci.69(5), 609–615 (2007).
   Google Scholar
• SegallMatthew. Rules For Drug Discovery: can simple property criteria help you to find a drug?. Drug Discovery World (DDW) ( Spring2014).
   Google Scholar
• VeberDF , JohnsonSR , ChengHY , SmithBR , WardKW , KoppleKD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem.45(12), 2615–2623 (2002).
   PubMed Web of Science ®Google Scholar
• SchneiderG. Prediction of Drug-Like Properties. In: Madame Curie Bioscience Database.Landes Bioscience, TX, USA, 2000–2013. https://www.ncbi.nlm.nih.gov/books/NBK6404/
   Google Scholar
• PajouheshH , LenzGR. Medicinal chemical properties of successful central nervous system drugs. NeuroRx2(4), 541–553 (2005).
   PubMedGoogle Scholar
• VeberDF , JohnsonSR , ChengHY , SmithBR , WardKW , KoppleKD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem.45(12), 2615–2623 (2002).
   PubMed Web of Science ®Google Scholar
• BarretR. Importance and Evaluation of the Polar Surface Area (PSA and TPSA). In: Therapeutical Chemistry.Elsevier, Amsterdam, The Netherlands, 89–95 (2018).
   Google Scholar
• KondoHX , KusakaA , KitakawaCKet al.Hydrogen bond donors and acceptors are generally depolarized in α-helices as revealed by a molecular tailoring approach. J. Comput. Chem.40(23), jcc.25859 (2019).
   Web of Science ®Google Scholar
• DahlgrenD , LennernäsH. Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches. Pharmaceutics.11(8), 411 (2019).
   PubMed Web of Science ®Google Scholar
• VertzoniM , AugustijnsP , GrimmMet al.Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review. Eur. J. Pharm. Sci.134, 153–175 (2019).
   PubMed Web of Science ®Google Scholar
• MueggeI , HealdSL , BrittelliD. Simple selection criteria for drug-like chemical matter. J. Med. Chem.44(12), 1841–1846 (2001).
   PubMed Web of Science ®Google Scholar
• MueggeI , HealdSL , BrittelliD. Simple selection criteria for drug-like chemical matter. J. Med. Chem.44(12), 1841–1846 (2001).
   PubMed Web of Science ®Google Scholar
• NomeirAA , MorrisonR , PreluskyDet al.Estimation of the extent of oral absorption in animals from oral and intravenous pharmacokinetic data in drug discovery. J. Pharm. Sci.98(11), 4027–4038 (2009).
   PubMed Web of Science ®Google Scholar
• FeixasF , LindertS , SinkoW , McCammonJA. Exploring the role of receptor flexibility in structure-based drug discovery. Biophys. Chem.186, 31–45 (2014).
   PubMed Web of Science ®Google Scholar
• AmaralM , KokhDB , BomkeJet al.Protein conformational flexibility modulates kinetics and thermodynamics of drug binding. Nat. Commun.8(1), 2276 (2017).
   PubMedGoogle Scholar
• AzadI , NasibullahM , KhanT , HassanF , AkhterY. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents. J. Mol. Graph. Model.81, 211–228 (2018).
   PubMed Web of Science ®Google Scholar
• SawaleRT , KalyankarTM , GeorgeR , DeosarkarSD. Molar Refraction and Polarizability of Antiemetic drug 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2 methoxybenzamide hydrochloride monohydrate in {Aqueous-Sodium or Lithium Chloride} Solutions at 30 o C. J. Appl. Pharm. Sci.6(03), 120–124 (2016).
   Google Scholar
• VermaJ , KhedkarVM , CoutinhoEC. 3D-QSAR in drug design–a review. Curr Top Med Chem.10(1), 95–115 (2010).
   PubMed Web of Science ®Google Scholar
• KatritzkyAR , KuanarM , SlavovSet al.Quantitative correlation of physical and chemical properties with chemical structure: utility for prediction. Chem. Rev.110(10), 5714–5789 (2010).
   PubMed Web of Science ®Google Scholar
• KhanT , DixitS , AhmadRet al.Molecular docking, PASS analysis, bioactivity score prediction, synthesis, characterization and biological activity evaluation of a functionalized 2-butanone thiosemicarbazone ligand and its complexes. J. Chem. Biol.10(3), 91–104 (2017).
   PubMedGoogle Scholar
• BennionBJ , BeNA , McNerneyMWet al.Predicting a Drug's Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data. J Phys Chem B.121(20), 5228–5237 (2017).
   PubMed Web of Science ®Google Scholar
• AlavijehMS , ChishtyM , QaiserMZ , PalmerAM. Drug metabolism and pharmacokinetics, the blood–brain barrier, and central nervous system drug discovery. NeuroRx.2(4), 554–571 (2005).
   PubMedGoogle Scholar
• KhanT , LawrenceAJ , AzadI , RazaS , KhanAR. Molecular Docking Simulation with Special Reference to Flexible Docking Approach. JSM Chem.6(1), 1053 (2018).
   Google Scholar
• AlWasidi AS , HassanAS , NaglahAM. In vitro cytotoxicity and druglikeness of pyrazolines and pyridines bearing benzofuran moiety. J. Appl. Pharm. Sci.10(04), 142–148 (2020).
   Google Scholar
• BritoMA , AraújoDe Brito M. Pharmacokinetic study with computational tools in the medicinal chemistry course. Braz. J. Pharm. Sci.47(4), 797–805 (2011).
   Web of Science ®Google Scholar
• HammadS , Bouaziz-TerrachetS , MeghnemR , MezianeD. Pharmacophore development, drug-likeness analysis, molecular docking, and molecular dynamics simulations for identification of new CK2 inhibitors. J. Mol. Model.26(6), 1–17 (2020).
   Web of Science ®Google Scholar
• PolêtoMD , RusuVH , GrisciBI , DornM , LinsRD , VerliH. Aromatic Rings Commonly Used in Medicinal Chemistry: Force Fields Comparison and Interactions With Water Toward the Design of New Chemical Entities. Front. Pharmacol.9(APR), 395 (2018).
   PubMedGoogle Scholar
• AldeghiM , MalhotraS , SelwoodDL , ChanAWE. Two- and three-dimensional rings in drugs. Chem. Biol. Drug Des.83(4), 450–461 (2014).
   PubMed Web of Science ®Google Scholar
• GiordanettoF , JinC , WillmoreL , FeherM , ShawDE. Fragment Hits: What do They Look Like and How do They Bind?. J. Med. Chem.62(7), 3381–3394 (2019).
   PubMed Web of Science ®Google Scholar
• BrocksDR. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharm. Drug Dispos.27(8), 387–406 (2006).
   PubMed Web of Science ®Google Scholar
• NguyenLA , HeH , Pham-HuyC. Chiral drugs: an overview. Int. J. Biomed. Sci.2(2), 85–100 (2006).
   PubMedGoogle Scholar
• ZhouY , WuS , ZhouHet al.Chiral pharmaceuticals: environment sources, potential human health impacts, remediation technologies and future perspective. Environ. Int.121, 523–537 (2018).
   PubMed Web of Science ®Google Scholar
• InakiM , LiuJ , MatsunoK. Cell chirality: its origin and roles in left-right asymmetric development. Philos. Trans. R. Soc. B Biol. Sci.371(1710), 20150403 (2016).
   PubMed Web of Science ®Google Scholar
• KerruN , GummidiL , MaddilaS , GanguKK , JonnalagaddaSB. A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules25(8), 1909 (2020).
   PubMed Web of Science ®Google Scholar
• JampilekJ. Heterocycles in Medicinal Chemistry. Molecules24(21), 3839 (2019).
   PubMed Web of Science ®Google Scholar
• TaylorAP , RobinsonRP , FobianYM , BlakemoreDC , JonesLH , FadeyiO. Modern advances in heterocyclic chemistry in drug discovery. Org. Biomol. Chem.14(28), 6611–6637 (2016).
   PubMed Web of Science ®Google Scholar
• BodaK , SeidelT , GasteigerJ. Structure and reaction based evaluation of synthetic accessibility. J. Comput. Aided. Mol. Des.21(6), 311–325 (2007).
   PubMed Web of Science ®Google Scholar
• ErtlP , SchuffenhauerA. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminform.1(1), 8 (2009).
   PubMed Web of Science ®Google Scholar
• AzadI , AhmadR , KhanTet al.Phenanthridine derivatives as promising new anticancer agents: synthesis, biological evaluation and binding studies. Future Med. Chem.12(8), 709–739 (2020).
   PubMed Web of Science ®Google Scholar
• RasulevB. Recent developments in 3D QSAR and molecular docking studies of organic and nanostructures. In: Handbook of Computational Chemistry.LeszczynskiJ, Kaczmarek-KedzieraA, PuzynTG, PapadopoulosM, ReisHK, ShuklaM (Eds). Springer International Publishing, Cham, Switzerland, 2133–2161 (2017).
   Google Scholar
• MartinekTA , ÖtvösF , DervaricsM , TóthG , FülöpF. Ligand-based prediction of active conformation by 3D-QSAR flexibility descriptors and their application in 3 + 3D-QSAR models. J. Med. Chem.48(9), 3239–3250 (2005).
   PubMed Web of Science ®Google Scholar
• KhanMF , VermaG , AkhtarWet al.Pharmacophore modeling, 3D-QSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents. Arab. J. Chem.12(8), 5000–5018 (2019).
   Web of Science ®Google Scholar
• KutlushinaA , KhakimovaA , MadzhidovT , PolishchukP. Ligand-based pharmacophore modeling using novel 3D pharmacophore signatures. Molecules.23(12), 3094 (2018).
   PubMed Web of Science ®Google Scholar
• PalS , KumarV , KunduBet al.Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors. Comput. Struct. Biotechnol. J.17, 291–310 (2019).
   PubMed Web of Science ®Google Scholar
• ShimJ , MacKerellAD. Computational ligand-based rational design: role of conformational sampling and force fields in model development. Medchemcomm2(5), 356–370 (2011).
   PubMed Web of Science ®Google Scholar
• KatsilaT , SpyrouliasGA , PatrinosGP , MatsoukasMT. Computational approaches in target identification and drug discovery. Comput. Struct. Biotechnol. J.14, 177–184 (2016).
   PubMed Web of Science ®Google Scholar
• AwaleM , ReymondJL. The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data. J. Cheminform.9(1), 1–10 (2017).
   PubMedGoogle Scholar
• BacilieriM , MoroS. Ligand-Based Drug Design Methodologies in Drug Discovery Process: An Overview. Curr. Drug Discov. Technol.3(3), 155–165 (2007).
   Google Scholar
• SukumarN , DasS , SukumarN. Current Trends in Virtual High Throughput Screening Using Ligand-Based and Structure-Based Methods. Comb. Chem. High Throughput Screen.14(10), 872–888 (2011).
   PubMed Web of Science ®Google Scholar
• Cereto-MassaguéA , OjedaMJ , VallsC , MuleroM , Garcia-VallvéS , PujadasG. Molecular fingerprint similarity search in virtual screening. Methods.71(C), 58–63 (2015).
   PubMedGoogle Scholar
• BajuszD , RáczA , HébergerK. Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?J. Cheminform.7(1), 20 (2015).
   PubMedGoogle Scholar
• KhalifaA Al , HaranczykM , HollidayJ. Comparison of nonbinary similarity coefficients for similarity searching, clustering and compound selection. J. Chem. Inf. Model.49(5), 1193–1201 (2009).
   PubMed Web of Science ®Google Scholar
• DrwalMN , GriffithR. Combination of ligand- and structure-based methods in virtual screening. Drug Discov. Today Technol.10(3), e395–401 (2013).
   PubMedGoogle Scholar
• HuG , KuangG , XiaoW , LiW , LiuG , TangY. Performance evaluation of 2D fingerprint and 3D shape similarity methods in virtual screening. J. Chem. Inf. Model.52(5), 1103–1113 (2012).
   PubMed Web of Science ®Google Scholar
• GombarV , SilverI , ZhaoZ. Role of ADME Characteristics in Drug Discovery and Their In Silico Evaluation: in Silico Screening of Chemicals for their Metabolic Stability. Curr. Top. Med. Chem.3(11), 1205–1225 (2005).
   Web of Science ®Google Scholar
• ChengF , LiW , ZhouYet al.AdmetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J. Chem. Inf. Model.52(11), 3099–3105 (2012).
   PubMed Web of Science ®Google Scholar
• YangH , LouC , SunLet al.admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics.35(6), 1067–1069 (2019).
   PubMed Web of Science ®Google Scholar
• DainaA , MichielinO , ZoeteV. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep.7, 42717 (2017).
   PubMed Web of Science ®Google Scholar
• KhanT , LawrenceAJ , AzadI , RazaS , JoshiS , KhanAR. Computational Drug Designing and Prediction Of Important Parameters Using in silico Methods- A Review. Curr. Comput. Aided. Drug Des.15(5), 384–397 (2019).
   PubMed Web of Science ®Google Scholar
• LohidashanK kumar , RajanM , GaneshA , PaulM , JerinJ. Pass and Swiss ADME collaborated in silico docking approach to the synthesis of certain pyrazoline spacer compounds for dihydrofolate reductase inhibition and antimalarial activity. Bangladesh J. Pharmacol.13(2018), 23–29 (2018).
   Google Scholar
• Viana NunesAM , dasChagas Pereira de Andrade F , FilgueirasLAetal.preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: a possible control for canine visceral leishmaniasis?Environ. Toxicol. Pharmacol.80, 103470 (2020).
   PubMed Web of Science ®Google Scholar
• HouTJ , XuXJ. ADME Evaluation in Drug Discovery. 3. Modeling Blood–Brain Barrier Partitioning Using Simple Molecular Descriptors. J. Chem. Inf. Comput. Sci.43(6), 2137–2152 (2003).
   PubMedGoogle Scholar
• Mangas-SanjuanV , González-AlvarezM , Gonzalez-AlvarezI , BermejoM. Drug penetration across the blood–brain barrier: an overview. Ther. Deliv.1(4), 535–562 (2010).
   PubMedGoogle Scholar
• DholakiaD , GoyalS , JamalS , SinghA , DasA , GroverA. Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs. BMC Bioinformatics.17(Suppl. 19), 512 (2016).
   PubMedGoogle Scholar
• GuanL , YangH , CaiYet al.ADMET-score-a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm.10(1), 148–157 (2019).
   PubMed Web of Science ®Google Scholar
• AwortweC , FasinuPS , RosenkranzB. Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges [Internet]. J. Pharm. Pharm. Sci.17(1), 1 (2014).
   PubMed Web of Science ®Google Scholar
• Van BreemenRB , LiY. Caco-2 cell permeability assays to measure drug absorption. Expert Opin. Drug Metab. Toxicol.1(2), 175–185 (2005).
   PubMedGoogle Scholar
• KhanT , AzadI , AhmadRet al.Synthesis, characterization, computational studies and biological activity evaluation of CU, FE, CO and ZN complexes with 2-butanone thiosemicarbazone and 1,10-phenanthroline ligands as anticancer and antibacterial agents. EXCLI J.17, 331–348 (2018).
   PubMed Web of Science ®Google Scholar
• AzadI , AkhterY , KhanTet al.Synthesis, quantum chemical study, AIM simulation, in silico ADMET profile analysis, molecular docking and antioxidant activity assessment of aminofuran derivatives. J. Mol. Struct.1203, 127285 (2020).
   Web of Science ®Google Scholar
• HaddaT Ben , RastijaV , AlMalkiFet al.Petra/Osiris/Molinspiration and Molecular Docking Analyses of 3-Hydroxy-Indolin-2-one Derivatives as Potential Antiviral Agents. Curr. Comput. Aided. Drug Des.17(1), 123–133 (2021).
   PubMed Web of Science ®Google Scholar
• HerrS , Myers-DeanJ , ReadH , JagodzinskiF. PETRA: Drug Engineering via Rigidity Analysis. Molecules.25(6), 1304 (2020).
   PubMed Web of Science ®Google Scholar
• AzadI , JafriA , KhanTet al.Evaluation of pyrrole-2,3-dicarboxylate derivatives: synthesis, DFT analysis, molecular docking, virtual screening and in vitro anti-hepatic cancer study. J. Mol. Struct.1176, 314–334 (2019).
   Web of Science ®Google Scholar
• KhanT , AhmadR , AzadI , RazaS , JoshiS , KhanAR. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone. Comput. Biol. Chem.75, 178–195 (2018).
   PubMed Web of Science ®Google Scholar
• JarrahpourA , FathiJ , MimouniMet al.Petra, Osiris and Molinspiration (POM) together as a successful support in drug design: antibacterial activity and biopharmaceutical characterization of some azo Schiff bases. Med. Chem. Res.21(8), 1984–1990 (2012).
   Web of Science ®Google Scholar
• IssaNT , WathieuH , OjoA , ByersSW , DakshanamurthyS. Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools. Curr. Drug Metab.18(6), 556 (2017).
   PubMed Web of Science ®Google Scholar
• ZhangZ , TangW. Drug metabolism in drug discovery and development. Acta Pharm. Sin.B8(5), 721–732 (2018).
   Google Scholar
• JamunaS , RathinavelA , MohammedSadullah S , DevarajS. In silico approach to study the metabolism and biological activities of oligomeric proanthocyanidin complexes. Indian J. Pharmacol.50(5), 242 (2018).
   PubMed Web of Science ®Google Scholar
• Djoumbou-FeunangY , FiamonciniJ , Gil-de-la-FuenteA , GreinerR , ManachC , WishartDS. BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification. J. Cheminform.11(1), 2 (2019).
   PubMed Web of Science ®Google Scholar
• WaseemD , ButtAF , HaqI ul , BhattiMH , KhanGM. Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents. DARU, J. Pharm. Sci.25(1), 1–14 (2017).
   Google Scholar
• Flores-HolguínN , FrauJ , Glossman-MitnikD. Computational prediction of bioactivity scores and chemical reactivity properties of the parasin i therapeutic peptide of marine origin through the calculation of global and local conceptual dft descriptors. Theor. Chem. Acc.138(6), 1–9 (2019).
   Web of Science ®Google Scholar
• HusainA , AhmadA , KhanSA , AsifM , BhutaniR , Al-AbbasiFA. Synthesis, molecular properties, toxicity and biological evaluation of some new substituted imidazolidine derivatives in search of potent anti-inflammatory agents. Saudi Pharm. J.24(1), 104–114 (2016).
   PubMed Web of Science ®Google Scholar
• Flores-HolguínN , FrauJ , Glossman-MitnikD. Chemical-reactivity properties, drug likeness, and bioactivity scores of seragamides A-F anticancer marine peptides: conceptual density functional theory viewpoint. Computation.7(3), 52 (2019).
   Web of Science ®Google Scholar
• JazayeriA , DiasJM , MarshallFH. From G Protein-coupled Receptor Structure Resolution to Rational Drug Design. J. Biol. Chem.290(32), 19489–19495 (2015).
   PubMed Web of Science ®Google Scholar
• RajagopalK , LefkowitzRJ , RockmanHA. When 7 transmembrane receptors are not G protein-coupled receptors. J. Clin. Invest.115(11), 2971–2974 (2005).
   PubMed Web of Science ®Google Scholar
• BhullarKS , LagarónNO , McGowanEMet al.Kinase-targeted cancer therapies: progress, challenges and future directions. Mol. Cancer.17(1), 48 (2018).
   PubMedGoogle Scholar
• MazairaGI , ZgajnarNR , LotufoCMet al.The Nuclear Receptor Field: A Historical Overview and Future Challenges. Nucl. Recept. Res.5, 101320 (2018).
   PubMedGoogle Scholar
• LloydMD. High-Throughput Screening for the Discovery of Enzyme Inhibitors. J. Med. Chem.63(19), 10742–10772 (2020).
   PubMed Web of Science ®Google Scholar
• FontesR , RibeiroJM , SilleroA. Inhibition and activation of enzymes. The effect of a modifier on the reaction rate and on kinetic parameters. Acta Biochim. Pol.47(1), 233–257 (2000).
   PubMed Web of Science ®Google Scholar
• NevesBJ , BragaRC , Melo-FilhoCC , Moreira-FilhoJT , MuratovEN , AndradeCH. QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery. Front. Pharmacol.9(NOV), 1275 (2018).
   PubMedGoogle Scholar
• KwonS , BaeH , JoJet al.Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinformatics20, 521 (2019).
   PubMed Web of Science ®Google Scholar
• OlandersG , AlogheliH , BrandtP , KarlénA. Conformational analysis of macrocycles: comparing general and specialized methods. J. Comput. Aided. Mol. Des.34(3), 231–252 (2020).
   PubMed Web of Science ®Google Scholar
• PerolaE , CharifsonPS. Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding. J. Med. Chem.47(10), 2499–2510 (2004).
   PubMed Web of Science ®Google Scholar
• FriedrichN-O , SimsirM , KirchmairJ. How Diverse Are the Protein-Bound Conformations of Small-Molecule Drugs and Cofactors?Front. Chem.6(MAR), 68 (2018).
   PubMedGoogle Scholar
• CherkasovA , MuratovEN , FourchesDet al.QSAR modeling: where have you been? Where are you going to?. J. Med. Chem.57(12), 4977–5010 (2014).
   PubMed Web of Science ®Google Scholar
• KlebeG , AbrahamU , MietznerT. Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules To Correlate and Predict Their Biological Activity. J. Med. Chem.37(24), 4130–4146 (1994).
   PubMed Web of Science ®Google Scholar
• KimKH. Comparative molecular field analysis (CoMFA). In: Molecular Similarity in Drug Design.DeanPM (Ed.). Springer Netherlands, Dordrecht, The Netherlands, 291–331 (1995).
   Google Scholar
• FoscatoM , JensenVR. Automated in Silico Design of Homogeneous Catalysts. ACS Catal.10(3), 2354–2377 (2020).
   Web of Science ®Google Scholar
• ToulhoatH. Heterogeneous Catalysis: Use of Density Functional Theory. In: Encyclopedia of Materials: Science and Technology.Elsevier, Amsterdam, The Netherlands, 1–7 (2010).
   Google Scholar
• CuiQ. Perspective: quantum mechanical methods in biochemistry and biophysics. J. Chem. Phys.145(14), 140901 (2016).
   PubMed Web of Science ®Google Scholar
• SahniV , SahniV. The Hohenberg-Kohn Theorems and Kohn-Sham Density Functional Theory. In: Quantal Density Functional Theory.Springer, Berlin, Heidelberg, Germany, 99–123 (2004).
   Google Scholar
• MerzKM. Using quantum mechanical approaches to study biological systems. Acc. Chem. Res.47(9), 2804–2811 (2014).
   PubMed Web of Science ®Google Scholar
• ArodolaOA , SolimanMES. Quantum mechanics implementation in drug-design workflows: does it really help?. Drug Des. Devel. Ther.11, 2551–2564 (2017).
   PubMed Web of Science ®Google Scholar
• CramerCJ , TruhlarDG. Density functional theory for transition metals and transition metal chemistry. Phys. Chem. Chem. Phys.11(46), 10757–10816 (2009).
   PubMed Web of Science ®Google Scholar
• HarveyJN. On the accuracy of density functional theory in transition metal chemistry. Annu. Reports Prog. Chem. - Sect.C102(1), 203–226 (2006).
   Google Scholar
• SliwoskiG , KothiwaleS , MeilerJ , LoweEW. Computational methods in drug discovery. Pharmacol. Rev.66(1), 334–395 (2014).
   PubMed Web of Science ®Google Scholar
• WilsonGL , LillMA. Integrating structure-based and ligand-based approaches for computational drug design. Future Med. Chem.3(6), 735–750 (2011).
   PubMed Web of Science ®Google Scholar
• TanL , GeppertH , SisayMT , GütschowM , BajorathJ. Integrating structure- and ligand-based virtual screening: comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets. ChemMedChem.3(10), 1566–1571 (2008).
   PubMed Web of Science ®Google Scholar
• PolgarT , KeseruGM. Integration of Virtual and High Throughput Screening in Lead Discovery Settings. Comb. Chem. High Throughput Screen.14(10), 889–897 (2011).
   PubMed Web of Science ®Google Scholar
• GoodAC , KrystekSR , MasonJS. High-throughput and virtual screening: core lead discovery technologies move towards integration. Drug Discov. Today5(1 Suppl. 12), S61–S69 (2000).
   PubMed Web of Science ®Google Scholar
• TanrikuluY , KrügerB , ProschakE. The holistic integration of virtual screening in drug discovery. Drug Discov. Today18(7–8), 358–364 (2013).
   PubMed Web of Science ®Google Scholar
• HuangSY , LiM , WangJ , PanY. HybridDock: A Hybrid Protein-Ligand Docking Protocol Integrating Protein- and Ligand-Based Approaches. J. Chem. Inf. Model.56(6), 1078–1087 (2016).
   PubMed Web of Science ®Google Scholar
• LamPCH , AbagyanR , TotrovM. Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach. J. Comput. Aided. Mol. Des.32(1), 187–198 (2018).
   PubMed Web of Science ®Google Scholar
• MestresJ , KnegtelRMA. Similarity versus docking in 3D virtual screening. Perspect. Drug Discov. Des.20(1), 191–207 (2000).
   Google Scholar
• KrügerDM , EversA. Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors. ChemMedChem.5(1), 148–158 (2010).
   PubMed Web of Science ®Google Scholar
• ShihHP , ZhangX , AronovAM. Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications. Nat. Rev. Drug Discov.17(1), 19–33 (2018).
   PubMed Web of Science ®Google Scholar
• CorselloSM , BittkerJA , LiuZet al.The Drug Repurposing Hub: a next-generation drug library and information resource. Nat. Med.23(4), 405–408 (2017).
   PubMed Web of Science ®Google Scholar
• PushpakomS , IorioF , EyersPAet al.Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov.18(1), 41–58 (2018).
   PubMed Web of Science ®Google Scholar
• AndersenPI , IanevskiA , LysvandHet al.Discovery and development of safe-in-man broad-spectrum antiviral agents. Int. J. Infect. Dis.93, 268–276 (2020).
   PubMed Web of Science ®Google Scholar
• ItoK , OhmagariN , MikamiA , SugiuraW. Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan. Glob. Heal. Med.2(2), 96–101 (2020).
   PubMedGoogle Scholar
• YousefifardM , ZaliA , MohamedAli Ket al.Antiviral therapy in management of COVID-19: a systematic review on current evidence. Arch. Acad. Emerg. Med.8(1), e45 (2020).
   PubMedGoogle Scholar
• KharkarPS , WarrierS , GaudRS. Reverse docking: a powerful tool for drug repositioning and drug rescue. Future Med. Chem.6(3), 333–342 (2014).
   PubMed Web of Science ®Google Scholar
• dosSantos Nascimento IJ , de AquinoTM , da Silva-JúniorEF. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections. Curr. Med. Chem.28(15), 2887–2942 (2020).
   Web of Science ®Google Scholar
• HatzimouratidisK. Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence. Clin. Interv. Aging.1(4), 403 (2006).
   PubMed Web of Science ®Google Scholar
• PalumboA , FaconT , SonneveldPet al.Thalidomide for treatment of multiple myeloma: 10 years later. Blood111(8), 3968–3977 (2008).
   PubMed Web of Science ®Google Scholar
• ChaeYK , AryaA , MalecekMKet al.Repurposing metformin for cancer treatment: current clinical studies. Oncotarget.7(26), 40767 (2016).
   PubMed Web of Science ®Google Scholar
• RascolO , FabbriM , PoeweW. Amantadine in the treatment of Parkinson's disease and other movement disorders. Lancet. Neurol.20(12), 1048–1056 (2021).
   PubMed Web of Science ®Google Scholar
• AmaralL , ViveirosM. Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action. Antibiotics.6(1), 3 (2017).
   Google Scholar
• HennekensCH , DykenML , FusterV. Aspirin as a Therapeutic Agent in Cardiovascular Disease. Circulation96(8), 2751–2753 (1997).
   PubMed Web of Science ®Google Scholar
• SohelAJ , ShutterMC , MollaM. Fluoxetine. xPharm Compr. Pharmacol. Ref.1–9 (2022).
   Google Scholar
• OgrendikM. Antibiotics for the treatment of rheumatoid arthritis. Int. J. Gen. Med.7, 43 (2014).
   Google Scholar
• WiffenPJ , DerryS , BellRFet al.Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst. Rev.2017(6), CD007938 (2017).
   Google Scholar
• WangF , WuFX , LiCZet al.ACID: a free tool for drug repurposing using consensus inverse docking strategy. J. Cheminform.11(1), 73 (2019).
   PubMed Web of Science ®Google Scholar
• PlewczynskiD , ŁaźniewskiM , GrotthussM Von , RychlewskiL , GinalskiK. VoteDock: consensus docking method for prediction of protein-ligand interactions. J. Comput. Chem. [Internet].32(4), 568–581 (2011).
   PubMed Web of Science ®Google Scholar
• HuangLH , HeQS , LiuKet al.ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res.46(D1), D911–D917 (2018).
   PubMed Web of Science ®Google Scholar
• GilsonMK , LiuT , BaitalukM , NicolaG , HwangL , ChongJ. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res.44(D1), D1045–D1053 (2016).
   PubMed Web of Science ®Google Scholar
• TaboureauO , NielsenSK , AudouzeKet al.ChemProt: a disease chemical biology database. Nucleic Acids Res.39(Suppl. 1), D367–D372 (2011).
   PubMedGoogle Scholar
• VanhaelenQ , MamoshinaP , AliperAMet al.Design of efficient computational workflows for in silico drug repurposing. Drug Discov. Today22(2), 210–222 (2017).
   PubMed Web of Science ®Google Scholar